Ezra AI

Ezra AI is a New York-based healthcare technology company that utilizes advanced medical imaging techniques, such as MRI, and artificial intelligence (AI) to provide individuals with full-body cancer screening services. The company's primary focus is on early cancer detection, aiming to create a new standard for preventative care by advocating for regular cancer screenings.

Ezra AI's cancer screening protocol involves a comprehensive MRI scan that can detect cancer, precancerous lesions, and other actionable health conditions like aneurysms, polyps, and cysts in up to 13 organs for women and 11 organs for men. In addition to the full-body scan, the company also offers specialized lung and breast protocols for high-risk individuals, utilizing various imaging modalities.

One of Ezra AI's key offerings is its Prostate AI, an AI-powered solution designed to assist radiologists in analyzing and segmenting prostate MRI scans. The Prostate AI received FDA 510(k) clearance in October 2020, marking it as the first AI system of its kind to receive such clearance. The Prostate AI offers several benefits, including accurate prostate volume measurements, automatic lesion quantification, and 3D volume rendering capabilities, potentially improving radiologists' workflow efficiency and diagnostic accuracy.

Ezra AI partners with existing outpatient imaging facilities, such as RadNet, Inc., the largest outpatient imaging network in the US. As of 2019, the company's cancer screening programs were available in New York City, San Francisco, and Los Angeles through its partnership with RadNet.